Загрузка...
Shifting practice in definitive chemoradiation for localized esophageal cancer
BACKGROUND: The efficacy of carboplatin–paclitaxel in the trimodality setting was demonstrated in the cross trial. Because of better tolerance, that regimen has been adopted as an alternative for patients receiving definitive chemoradiation (dcrt). The purpose of our study was to compare outcomes in...
Сохранить в:
| Опубликовано в: : | Curr Oncol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Multimed Inc.
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5659162/ https://ncbi.nlm.nih.gov/pubmed/29089808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.24.3677 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|